2seventy bio, Inc. - Common Stock (TSVT)

Historical Holders from Q4 2021 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
TSVT on Nasdaq
Shares outstanding
52,406,487
Price per share
$5.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-95,972
Value change
-$507,987
Number of holders
0
Price from insider filings
$5.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 2seventy bio, Inc. - Common Stock (TSVT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 5.4% $13,928,177 2,819,469 The Vanguard Group 31 Mar 2025
GOLDMAN SACHS GROUP INC 0% $1,540 308 THE GOLDMAN SACHS GROUP, INC. 30 Jun 2025
As of 30 Sep 2025, 2seventy bio, Inc. - Common Stock (TSVT) has 0 institutional shareholders filing 13F forms. They reported no common stock holdings, but disclosed options positions.

Institutional Holders of 2seventy bio, Inc. - Common Stock (TSVT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 0 $0 -$507,987 $5.00 0
2025 Q2 95,972 $507,987 -$233,368,619 $9.92 2
2025 Q1 47,343,776 $233,886,684 +$26,350,039 $4.94 135
2024 Q4 45,950,596 $135,091,468 -$4,182,742 $2.94 115
2024 Q3 45,014,282 $212,478,889 -$12,126,217 $4.72 112
2024 Q2 47,616,386 $183,350,347 +$592,500 $3.85 111
2024 Q1 46,621,664 $249,450,601 -$1,931,167 $5.35 112
2023 Q4 66,432 $285,214 +$48,845 $4.27 3
2023 Q3 54,613,972 $214,034,507 -$17,299,298 $3.92 136
2023 Q2 49,687,789 $502,843,205 -$98,024 $10.12 142
2023 Q1 49,252,081 $502,455,508 +$169,328,092 $10.20 135
2022 Q4 32,662,831 $306,040,749 -$28,794,483 $9.37 128
2022 Q3 30,346,986 $441,553,883 -$10,396,460 $14.55 106
2022 Q2 32,093,805 $423,442,909 +$23,022,002 $13.20 111
2022 Q1 29,485,129 $502,950,358 +$214,314,530 $17.06 109
2021 Q4 17,190,552 $440,730,458 +$440,730,470 $25.63 105